Atossa receives Nasdaq minimum bid price deficiency notice; compliance period through Aug 20, 2025

ATOSSA THERAPEUTICS, INC.

Received Nasdaq deficiency notice on Feb 21, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days.
Compliance period ends Aug 20, 2025; possible additional 180-day extension if not compliant by then.
To regain compliance, common stock must close at $1.00+ for at least 10 consecutive business days.
Notice has no immediate effect on stock listing or trading; company monitoring and evaluating options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.